Phase III Study of Ocrelizumab in Patients with Primary Progressive Multiple Sclerosis: ORATORIO Study Design

被引：0
作者：
Montalban, Xavier
Wolinsky, Jerry
Yin, Ming
Leppert, David
Glanzman, Robert
Chin, Peter
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A319 / A320
页数：2
相关论文
共 50 条
[41]   Safety of ocrelizumab in multiple sclerosis: updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Hughes, R. ;
Koendgen, H. ;
McNamara, J. ;
Pradhan, A. ;
Wormser, D. ;
Wolinsky, J. S. .
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 :697-698
[42]   Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients With Relapsing and Primary Progressive Multiple Sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Prajapati, K. ;
Koendgen, H. ;
Craveiro, L. ;
Hughes, R. ;
Pradhan, A. ;
Wolinsky, J. .
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) :68-69
[43]   Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis [J].
Hauser, S. L. ;
Kappos, L. ;
Montalban, X. ;
Koendgen, H. ;
Li, C. ;
Marcillat, C. ;
Pradhan, A. ;
Wormser, D. ;
Wolinsky, J. S. .
EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 :334-334
[44]   Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis [J].
Kappos, Ludwig ;
Hauser, Stephen ;
Montalban, Xavier ;
Buffels, Regine ;
Chin, Peter ;
Li, Carrie ;
Mortensen, Deborah ;
Napieralski, Julie ;
Van Beek, Johan ;
Wormser, David ;
Wolinsky, Jerry .
NEUROLOGY, 2017, 88
[45]   Safety of ocrelizumab in multiple sclerosis: Updated analysis in patients with relapsing and primary progressive multiple sclerosis [J].
Hauser, S. ;
Kappos, L. ;
Montalban, X. ;
Craveiro, L. ;
Hughes, R. ;
McNamara, J. ;
Pradhan, A. ;
Wormser, D. ;
Koendgen, H. ;
Wolinsky, J. S. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
[46]   Ocrelizumab infusion experience in patients with relapsing and primary progressive multiple sclerosis: Results from the phase 3 randomized OPERA I, OPERA II, and ORATORIO studies [J].
Mayer, Lori ;
Kappos, Ludwig ;
Racke, Michael K. ;
Rammohan, Kottil ;
Traboulsee, Anthony ;
Hauser, Stephen L. ;
Julian, Laura ;
Kondgen, Harold ;
Li, Carrie ;
Napieralski, Julie ;
Zheng, Hanzhe ;
Wolinsky, Jerry S. .
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 30 :236-243
[47]   Ocrelizumab in Primary Progressive and Relapsing Multiple Sclerosis REPLY [J].
Hauser, Stephen L. ;
Belachew, Shibeshih ;
Kappos, Ludwig .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (17) :1694-1694
[48]   Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis [J].
Montalban, X. ;
Hauser, S. L. ;
Kappos, L. ;
Arnold, D. L. ;
Bar-Or, A. ;
Comi, G. ;
de Seze, J. ;
Giovannoni, G. ;
Hartung, H. -P. ;
Hemmer, B. ;
Lublin, F. ;
Rammohan, K. W. ;
Selmaj, K. ;
Traboulsee, A. ;
Sauter, A. ;
Masterman, D. ;
Fontoura, P. ;
Belachew, S. ;
Garren, H. ;
Mairon, N. ;
Chin, P. ;
Wolinsky, J. S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (03) :209-220
[49]   Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial: 6.5-study year follow-up data [J].
Wolinsky, J. S. ;
Brochet, B. ;
Hartung, H. -P. ;
Naismith, R. T. ;
Airas, L. ;
Coutant, K. ;
Koendgen, H. ;
Manfrini, M. ;
Mehta, L. ;
Prajapati, K. ;
Kappos, L. .
MULTIPLE SCLEROSIS JOURNAL, 2019, 25 :56-57
[50]   Study Design and Baseline Characteristics of the INFORMS Study: Fingolimod in Patients with Primary Progressive Multiple Sclerosis [J].
Miller, David ;
Cree, Bruce ;
Dalton, Catherine ;
Freedman, Mark ;
Hartung, Hans ;
Kappos, Ludwig ;
Lubetzki, Catherine ;
Lublin, Fred ;
MacManus, David ;
Montalban, Xavier ;
Weiner, Howard ;
Wolinsky, Jerry ;
De Vera, Ana ;
Kornyeyeva, Elena ;
Li, Bingbing ;
Pirozzi, Claudia ;
von Rosenstiel, Philipp ;
Polman, Chris .
NEUROLOGY, 2013, 80
12345